In this synopsis of a basic science topic for a psychology journal, we describe one of the longest known biological systems that depends on both genetic and environmental factors, the vitamin A or retinoid system. This theme is relevant to mental pathology because of longstanding suggestions that vitamin A plays a role in psychiatric diseases (Goodman, 1995 (Goodman, , 1998 LaMantia, 1999) , an idea that has over time been outpaced, however, by the scientific progress in cognitive disciplines. At the current rapid rate of advancement, any scientific hypothesis that is around for a long time but is not backed up by conclusive evidence risks the reputation of being expendable. Although an involvement of retinoids in psychiatric diseases was seen as a very plausible proposition some years ago, it is now rarely mentioned in genetic reviews (Harrison & Weinberger, 2005) . Here we want to demonstrate to a general readership that the term retinoids does not refer to a superseded theme but to an enormous molecular field whose role in brain function still needs to be integrated with cognitive neuroscience.
The conviction that cognitive abilities and their disorders are inherited is an implicit consequence of our Darwinian history: Evolutionary selection in all species with sexual reproduction depends on the judgment of their genetic quality. With increasing appreciation of heredity as an algorithmic process, this natural instinct could give rise to eugenics, with disastrous consequences for mentally impaired individuals. The social upheaval of the 1960s and 1970s favored a reversal in theories about the causations of cognitive impairments, away from genetic and toward environmental explanations. Theories of "bad mothers" causing psychiatric diseases, however, led to other unfortunate consequences. Over the last decades, a gradual emancipation of cognitive and psychiatric reasoning from ideological influences was prompted by neuropathological detections of indisputable anatomical abnormalities in psychiatric brains and, increasingly, by the staggering advance in genetic science. The statement that cognitive diseases have both genetic and environmental causes does not anymore trigger the accusation of a politically incorrect mindset; rather, it is nowadays common to refer to the relative percentages of genetic versus environmental contributions as set characteristics of specific psychiatric diseases.
Despite the enormous progress in the genetic and neurobiological understanding of cognitive disorders, however, many of their complex aspects, including the mechanisms of combining different etiological contributions, remain unexplained. For instance, it is incompletely understood how mutations in a diverse list of genes can cause similar clinical symptoms; why an assortment of widely distributed brain sites can be simultaneously affected; or how qualitatively different environmental and genetic disturbances can have quantitatively additive effects in the causation of cognitive diseases. Here we summarize some basic characteristics of the retinoid system and review observations on vitamin A actions in the brain in order to stipulate a role in normal brain function and to explain the mechanisms through which retinoids can contribute to the perplexing components of cognitive disorders.
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General Characteristics of Retinoid Actions
All of vitamin A originates in plants; animals cannot synthesize it de novo, but they can process it enzymatically to its two active forms: retinaldehyde, the visual chromophore, and retinoic acid (RA), which regulates gene expression (Blomhoff & Blomhoff, 2006) . From transcriptome studies on human stem cells, it is estimated that RA can change the transcription of about 15% of all protein-coding genes and 23% of noncoding ribonucleic acids (RNAs) by twofold or more (Cawley et al., 2004) . RA tends to promote cellular differentiation. In medicine RA is pharmacologically applied for its capacity to stop cell division and initiate differentiation of hyperproliferous skin cells in acne and of malignant proliferation in several forms of cancer. Vitamin A is an essential nutrient, but in contrast to most other vitamins, both excess and deficiency are harmful (Clagett-Dame & DeLuca, 2002) . In early embryos, both too much and too little RA cause malformations at similar sites and developmental stages, indicating that precise RA levels are critical at particular locations during brief times, the critical periods in retinoid teratology (Shenefelt, 1972) ; at all other times, RA is required, but its precise regulation does not seem to be as critical. The many different retinoid-linked malformations phenocopy naturally occurring malformations in particular organs, which are caused by mutations in essential morphogenetic genes whose expression is regulated by RA (Batourina et al., 2005; Blomhoff & Blomhoff, 2006) . In epidemiological studies, the incidence of severe hereditary eye malformations was found to be several times higher in vitamin A deficient regions, suggesting that the expression of mild mutations in presumably RA-regulated genes can be brought out by environmental disturbances (Hornby, Ward, & Gilbert, 2003) . This characteristic of RA-to affect the expression of many genes in an environmentally sensitive way-was one of the reasons for the idea that retinoids must play a role in unexplained psychiatric diseases with both genetic and environmental etiologies.
Normal RA functions require many genetically encoded proteins in addition to a proper vitamin A supply in the food (Blomhoff & Blomhoff, 2006) . Among other functions, these proteins mediate retinoid uptake in the gut, storage in the liver, and transport across the circulation. Within cells retinoids are processed by several dehydrogenases that catalyze the reversible conversion of retinol to retinaldehyde and the irreversible conversion of retinaldehyde to RA. Once formed, RA is rapidly inactivated by cytochrome P450-linked oxidases, the CYP26 enzymes. RA acts by binding to nuclear receptors that are members of the large family of ligand-regulated transcription factors . RA receptors reside mainly in the nucleus at RA response elements (RAREs) in the promoters of the regulated genes. RA binding causes the receptor to recruit histone acetyl transferases (HATs) and transcriptional co-activators, which facilitate transcription; dissociation of RA from the receptor causes recruitment of histone deacetylases (HDACs) and transcriptional corepressors, which shut off expression of the gene.
In addition to the presence of RA, its absence can also be critical for the regulation of gene expression by the RA receptors. For instance, a repressive function of unliganded receptors is essential for proper head formation in early embryos (Koide, Downes, Chandraratna, Blumberg, & Umesono, 2001; Uehara et al., 2007; Weston, Blumberg, & Underhill, 2003) and for the maintenance of mature neuronal characteristics (Ballas, Grunseich, Lu, Speh, & Mandel, 2005) . The RA receptors include eight major RAR isoforms and six major RXR isoforms, and they tend to regulate transcription as RAR/RXR heterodimers . In addition, the RXRs heterodimerize with a wide range of other nuclear receptors, including the thyroid hormone, vitamin D, and PPAR receptors. Due to the large number of isoforms and the enormous number of different heterodimeric combinations, RA-binding receptors constitute by far the most elaborate subgroup of all nuclear receptors.
Most RA influence on gene expression is believed to be mediated by this classical pathway that involves binding of liganded RA receptors to RAREs in the promoters of regulated genes. Since functional RAREs cannot be predicted from genomic sequence searches alone but their verification requires multiple stringent criteria, the classic pathway has been proven only for a small number of genes (Balmer & Blomhoff, 2005; Jacobs et al., 2006; Lane & Bailey, 2005) . Of 532 genes listed in the most comprehensive compilation of RA regulation to date, only 27 are unquestionably direct targets of the classic pathway; the remaining genes include some that are likely to contain functional RAREs, a majority about which no information is available about transcriptional mechanisms, and 133 genes that are regulated indirectly, usually through a transcriptional intermediary (Balmer & Blomhoff, 2002) .
In addition to the classic pathway, evidence from a diverse range of in vitro studies points to the existence of nongenomic RA actions on cellular behavior, including cell survival or neurite outgrowth, or on transcription of genes that do not contain a RARE in their promoter (Aggarwal et al., 2006; Alique, Moreno, Kitamura, Xu, & Lucio-Cazana, 2006; Canon, Cosgaya, Scsucova, & Aranda, 2004; Dey et al., 2007; Ertesvag, Aasheim, Naderi, & Blomhoff, 2007; Fernandes, Sun, & Price, 2007; Hughes, Zhao, Chandraratna, & Brown, 2006; Liou et al., 2005; Masia, Alvarez, de Lera, & Barettino, 2007) . The mechanisms of nongenomic RA actions are generally poorly understood, and they vary in different cell lines. In some systems they require the presence of RA receptors, and in others they do not. When RA receptors are implicated, the nongenomic RA actions are believed either to involve direct binding of the liganded receptor to the regulated target protein in the cytoplasm (Liou et al., 2005) or to act via co-operation with the classical RA pathway in the nucleus (Ertesvag et al., 2007; Hughes et al., 2006) .
Recently it was shown that RARs contain a proline-rich domain through which they bind to c-SRC in the cytoplasm in a RAdependent manner (Dey et al., 2007) . A cytoplasmic localization of RA receptors, which normally reside in the nucleus, can be accomplished by phosphorylation of a site in the receptor's deoxyribonucleic acid (DNA) binding domain . The most common characteristic of noncanonical RA actions is their abolition by specific protein kinase inhibitors, although various different kinases have been implicated. As the proof of nongenomic RA actions requires tests that are best done on cultured cells, it is not clear how common they are in vivo or what the relative contributions are of classical versus noncanonical RA pathways to gene expression in the living organism.
Retinoids and the Environment
Vitamin A was originally discovered through the symptoms caused in humans by its nutritional deficiency, and for decades most information on the retinoid system was obtained by feeding pregnant experimental animals a vitamin A deficient diet over many months (Hale, 1937; Wilson, Roth, & Warkany, 1953) . When it was realized that vitamin A excess also causes embryonic malformations at similar sites and developmental stages as deficiency, brief applications of RA, which is rapidly degraded in vivo, provided a much more powerful method to probe for potential sites and stages of vitamin A actions in the developing embryo. With this method Shenefelt (1972) defined the RA-critical periods in embryonic rodents (hamsters). For the brain he found brief early periods during which RA overdoses cause exencephaly or holoprosencephaly ( Figure 1A) ; during later embryonic development the brain becomes much less vulnerable.
The RA-critical periods determined for the hamster brain occur at initial stages of brain-anlage formation and prior to or around neural tube closure, and they correspond to human brain development that is completed by end of the first month of gestation. Serious retinoid perturbations around that time tend to be lethal in all mammals, because they elicit malformations in vital organs such as the heart, which are incompatible with life. Because determining events in morphological brain growth extend over protracted times, and because mice are born at a stage of brain development reached in human gestation early in the second trimester, we continued the screens for RA-critical periods of the brain throughout the postnatal life of mice (Luo, Wagner, Crandall, & Dräger, 2004) . Brief applications of RA overdoses cause permanent neuroanatomical changes only during the initial 10 postnatal days, and they are invariably subtle. In the cerebral cortex, only a mild change in numbers and radial positions of parvalbumin-positive interneurons can be detected. By contrast to the minor anatomical consequences, the postnatal RA teratology is primarily manifested in severe, chronic behavioral abnormalities. During the early postnatal time the mice pass through a developmental window during which they are exceedingly sensitive to brief applications of low RA doses ( Figure 1B) , and the lasting behavioral symptoms depend exclusively on the time of perturbations. We found a wide range of abnormalities, all of which had previously been associated with damage to limbic brain regions. For instance, lasting severe hyperactivity and circling behavior could be elicited only during 2 to 3 postnatal days ( Figure 1C ). Because the spectra of developmental disturbances caused by retinoid perturbations are very similar in different mammals, the window of early postnatal RA vulnerability in mice ought to have a corresponding period in the later part of the second trimester in human development.
Hence, the teratological studies indicate that the developing mammalian brain contains two temporally separated major retinoid critical periods. Perturbations during the early one cause dramatic brain malformations, but since this period coincides with vulnerable times in vital organ formation, early retinoid abnormalities are often lethal (Clagett-Dame & DeLuca, 2002) . Perturbations during the second critical period, which occurs postnatally in mice, can cause lasting severe behavioral abnormalities but only subtle neuroanatomical effects (Luo, Wagner, Crandall, et al., 2004) . Existence of the early critical period has been abundantly demonstrated by both vitamin A deficiency and excess for many different species, but the only evidence for the later one comes from applications of RA overdoses. Accidental vitamin A poisoning practically does not occur in nature, but it represents an artificial, pharmacological by-product in humans, or an experimental tool in animals, which is justified by the observations that deficiency and excess affect similar sites and stages during early embryogenesis. Clinical findings in humans indicate that at least one of the parallel symptoms extends throughout life: Both vitamin A deficiency and excess can cause increased intracerebral pressure (pseudotumor cerebri) in adults (Panozzo, Babighian, & Bonora, 1998; Visani, Manfroi, Tosi, & Martinelli, 1996) .
The main naturally occurring perturbation in RA-regulated gene expression is vitamin A deficiency, which can be caused by several different forms of environmental disturbances. The best known of these is nutritional vitamin A deficiency, which is rare in rich countries but common worldwide (Underwood, 1994) . Moderate nutritional vitamin A deficiency is probably the explanation for the much higher rates of familial inborn eye malformations in some underdeveloped countries, because the eye is the most vulnerable organ during embryonic development, and it is not required for survival (Hornby, Dandona, Foster, Jones, & Gilbert, 2001; Hornby et al., 2000) . Psychiatric brain diseases whose pathogenesis might involve RA regulation, however, do not seem to be more common in poor countries, probably because marked nutritional deficiency kills embryos at early developmental stages, long before the brain passes through the second critical period. A form Figure 1 . The rodent brain has two temporally separated periods of increased retinoic acid vulnerability. A: Shenefelt (1972) mapped the early one in embryonic hamsters. B and C: Lasting behavioral abnormalities caused postnatally in mice by overdoses of retinoic acid (RA) given to young pups; for details see Luo, Wagner, Crandall, and Dräger (2004) . LD 50 ϭ half-lethal dose.
of vitamin A deficiency that can affect functional brain maturation needs to be limited in duration, which is well known to occur during an immune response (Ross & Hämmerling, 1994) . Postnatally the immune defense is the most vulnerable system to vitamin A deficiency, which justifies why an increased rate of measles infections is a commonly used epidemiological measure for borderline deficiency in poor countries (Underwood, 1994) . Also under normal, vitamin A sufficient conditions, the needs of the immune system take preference over all other RA-dependent processes in the body. Activation of an immune response causes a rapid drop in circulating vitamin A, because the transcription of its carrier serum retinol-binding protein (RBP) in the liver is turned off during immune activity-that is, RBP is a negative acute phase protein (Rosales & Ross, 1998) . In addition to shutting off the vitamin A transport to the embryo or brain, immune activity consumes a significant amount of the total body-vitamin A pool, and chronic infections can deplete it (Faivre, Gregoire, Preault, Cezilly, & Sorci, 2003) .
Another form of environmental vitamin A deficiency accompanies young age and premature birth, because the liver-storage capacity develops late; premature babies are always deficient, and young children are much more prone to develop deficiency symptoms than adults (Shenai, 1999) . A last form of environmental vitamin A deficiency is known to accompany intestinal malabsorption syndromes due to different causes, such as celiac disease. Malabsorption-related vitamin A deficiency can become so pronounced as to cause pseudotumor cerebri (el Ouahabi, Lorenzo, & Black, 1992; Panozzo et al., 1998) . All the perturbations that cause vitamin A deficiency are specifically known as environmental risk factors or comorbidities in several psychiatric diseases (Bromet & Fennig, 1999; Buka et al., 2001; Harrison & Weinberger, 2005) .
Retinoid Actions in Brain Functions
For most of the duration of retinoid research beginning early last century, the brain was not considered a retinoid target, because it was practically unharmed by the early experiments on nutritionally vitamin A deprived animals (Hale, 1937; Wilson et al., 1953) . Moreover, the retinoid content of the brain was known to be low. More recent measurements on the source of total RA contents in different organs of adult rats showed that almost 90% of brain RA is supplied by diffusion from the low plasma RA levels in the circulation, and only 10% is synthesized locally; for organs with well-established RA function, such as the testes or pancreas, these relative contributions are reversed (Kurlandsky, Gamble, Ramakrishnan, & Blaner, 1995) . With the elucidation of the mechanisms of retinoid actions, it became apparent that most proteins of the retinoid system are expressed in the postnatal brain and that their expression patterns differ from those in the embryo (Lane & Bailey, 2005) . This points to unique RA contributions to brain function. Multiple observations demonstrate critical RA involvements in important neurobiological activities, whose mechanisms are exhaustively analyzed in neuroscience, but the RA evidence is usually not considered in neurobiological studies of cognitive processes.
Part of the evidence for a RA involvement in learning, memory, and sleep derives from analyses of RA-receptor knockout mice: RAR␤ null-mutants lack long-term potentiation (LTP) in recordings from hippocampal slices; behaviorally, their long-term memory is severely impaired, and they have abnormal sleep and sleep EEG (Chiang et al., 1998; Maret et al., 2005) . It is interesting, however, that the RAR␤ is not expressed in the hippocampus, cerebral cortex, or thalamus, where these functions are generated, or, more likely, it is present here only in low amounts (Krezel, Kastner, & Chambon, 1999; Zetterström et al., 1999) . RA is required for formation of new neurons in the postnatal dentate gyrus, a process involved in normal cognition and mood regulation (Jacobs et al., 2006) . Nutritional vitamin A deficiency impairs memory and LTP in mice, and these defects can be cured by vitamin A supplementations (Cocco et al., 2002; Etchamendy et al., 2003; Misner et al., 2001 ). The cortex of deprived rats accumulates beta-amyloid deposits and other signs that parallel those in Alzheimer's disease (Corcoran, So, & Maden, 2004) , and normal memory loss in aging rats due to naturally occurring reductions in retinoid function with age can be alleviated by vitamin A supplements (Etchamendy et al., 2001 ). These observations do not suggest a simple way for memory enhancement, unfortunately, because dentate neurogenesis is also decreased in response to RA excess: Chronic exposure of mice to elevated RA levels reduces formation of new neurons here, and the mice exhibit impaired memory and depression-like behaviors ; O'Reilly, Shumake, Gonzalez-Lima, Lane, & Bailey, 2006) . Similarly, about 7% of humans treated with Accutane (13-cis RA) for acne develop symptoms of clinical depression (Hull & D'Arcy, 2005; O'Reilly et al., 2006) . Impaired dentate neurogenesis cannot explain a total loss of hippocampal LTP, and cortical memory does not depend on formation of new neurons. Changes of gene expression in learning and memory require that information about rapid physiological changes be transmitted faithfully to specific transcriptional events. RA levels, however, do not show any rapid physiological fluctuations, nor do any other retinoid genes undergo changes on a neurophysiological time scale (Blomhoff & Blomhoff, 2006) . Without doubt, the retinoid system itself does not possess the dynamic properties required for learning and memory. These problems, in addition to the very low endogenous RA synthesis in the brain and the unexplained phenomenon that null-mutant mice for a particular RA receptor have distinct functional deficits at sites, where in the normal brain only low levels of that receptor are present, reveal an overt discrepancy: Despite the incontrovertible evidence for a role of RA in brain activities, it is not clear how it can be integrated with the known molecular mechanisms of higher brain functions.
Localization of Retinoid Actions
Teratological observations on retinoid-linked malformations in different species indicate that RA actions are localized to distinct sites in the developing organism and that these sites undergo conserved movements throughout development. The determinants for this localization are apparent from observations of null-mutant mice generated for practically every retinoid gene : Most of the retinoid mutants do not have dramatic phenotypes except for null mutants of the metabolic enzymes, which tend to have severe deformities at the sites that are also vulnerable to nutritional vitamin A deficiency. This suggests that the most important criteria for the localization of preferential RA-signaling sites are locally regulated RA levels, or more likely, local RA-level differentials. The most critical enzymes for the local RA concentrations are the retinaldehyde dehydrogenases (RALDHs), which catalyze the conversion of retinaldehyde to RA (Blomhoff & Blomhoff, 2006) . During early development the local rates of RA synthesis are very high, and these depend also on a local supply of retinaldehyde generated by one of the enzymes that convert retinol to retinaldehyde, the retinol dehydrogenase RDH10 (Sandell et al., 2007) ; RDH10 is expressed at similar-although not identical-sites as the RALDHs in young embryos. The degradation of RA is catalyzed by several oxidases of the CYP26 enzyme family (Blomhoff & Blomhoff, 2006) . The importance of locally regulated RA-concentration differences as determinants of RA actions is consistent with the widely dispersed and sparse expression of the metabolic enzymes: They are restricted to a few sites in the body with much of the intervening tissue being free of RA-synthesizing or degrading enzymes, which is especially true for the brain. Other retinoid factors, in particular the many RA receptors that mediate the transcriptional complexity, are expressed profusely in overlapping ways and they serve partially redundant functions, so that their roles in simple localization are relatively minor .
RA Signaling in the Brain
The postnatal cerebral cortex of mice contains two RALDHs: RALDH2 and RALDH3 (Wagner, Luo, & Dräger, 2002) . As almost 90% of total RA content in the adult rodent brain originates from the circulation that perfuses the brain evenly (Kurlandsky et al., 1995) , the RALDHs mark local RA diffusion sources for cortical tissue close by, within which RA levels must be elevated above the general levels, and which represent sites of preferential RA signaling. In addition to the localization provided by RALDH expressions, the brain contains atypical mechanisms for localizing RA signaling, whose properties have been characterized with different RA reporter systems for embryonic and adult brains Luo, Wagner, Grün, & Dräger, 2004; Molotkova, Molotkov, & Duester, 2007) . These reporters are transgenic mouse strains, cell lines, or tissue explants transfected with genetic constructs containing the sensitive RA response element (RARE) from the RAR␤ driving the expression of reporter genes (usually ␤-galactosidase). Such reporter assays show that the RA responsiveness is not evenly distributed in the brain, as it is in most of the embryonic body, but that it can be magnified at selected sites by some unknown mechanisms (Luo, Wagner, Grün, et al., 2004) . Moreover, these sites of RA signaling in the brain gradually change their locations throughout development, consistent with their interpretation as indicators for select locations of neurogenesis and for critical events in neuronal differentiation.
At early developmental stages, the RA reporter indicates strong RA signaling at the ventricular surface of the dorsal telencephalon, the site of neurogenesis for the cerebral cortex (Luo, Wagner, Grün, et al., 2004) . This is illustrated for Embryonic Day 11 (E11) in Figure 2 , a schematic of developmental changes in RA signaling in the medio-dorsal cortex of mice. At E11 no RALDHs are expressed yet in the cortex, but the signaling is in response to RA diffusing from other RALDH expression sites via the ventricular lumen of the neural tube. Around E13-14 the RALDH2 enzyme becomes detectable in the meninges covering the cortex; its levels increase slowly up to a maximum in the newborn brain and then gradually decrease to low adult values (Smith, Wagner, Koul, McCaffery, & Dräger, 2001 ). This temporal change in meningeal RALDH2 expression causes a progressive reversal in RA signaling from an inside-out to an outside-in decline across the width of the cortex, as illustrated for E18 (Figure 2 ). Around the time of birth, expression of the RALDH3 enzyme becomes detectable centrally at the most medial edge of the cortex (Wagner et al., 2002; Wagner, Luo, Sakai, Parada, & Dräger, 2006) ; its territory expands and its levels increase over the following 2 days. At Postnatal Day 2 (P2, Figure 2 ), a continuous RALDH3 band delineates the entire rostro-caudal length of the medial cortical edge, the medial limbic cortex. Over the next few days this medial RALDH3 band shifts laterally (Figure 2, P8 ). In the caudal two thirds of cortical length, it trans-locates from the medial limbic cortex into the adjacent neocortical regions, which include the mouse equivalent of the dorsal visual stream, posterior parietal cortex, and parts of the secondary motor cortex. Rostrally, the RALDH3 band continues to mark the cingulate and medial prefrontal cortex (Wagner et al., 2006) . This topography is stable throughout life, but enzyme levels decrease gradually, as illustrated here schematically for P8 and P21 (Figure 2) . In contrast to the expression of RALDH2 in the meninges, RALDH3 is synthesized by neurons in cortical layers 2/3, which send axonal projections across the corpus callosum (Wagner et al., 2002) . It is not possible to visualize the distribution of the small diffusible lipid retinoic acid (RA) directly at a histological resolution. In this schematic of the dorsal telencephalic wall/cerebral cortex in developing mice, the hypothetical RA distribution is inferred from the changing geometry in brain anatomy and in expression sites of RA synthesizing retinaldehyde dehydrogenase (RALDH) enzymes that give rise to RA diffusion. As it is impossible to predict the exact shape of the RA gradients, the schematic represents the RA distribution that we consider as most likely but depicts it in the growing brain at same sizes. For details see Smith, Wagner, Koul, McCaffery, and Dräger (2001) , Wagner, Luo, and Dräger (2002) , and Wagner, Luo, Sakai, Parada, and Dräger (2006) . E ϭ Embryonic Day; P ϭ Postnatal Day; med. ϭ medially; lat. ϭ laterally.
In the Functional Cortex RALDH3 Co-Localizes With Attributes of Modifiable Circuits
The RALDH3 enzyme was first identified in the ventral half of the embryonic retina, where it generates exceedingly high RA concentrations (Li et al., 2000; McCaffery, Lee, Wagner, Sladek, & Dräger, 1992) . A critical morphogenetic role of these extreme RA levels is probably the explanation for why a reduction in the size of the ventral retina is the most sensitive manifestation of many different perturbations in retinoid actions (Dupe et al., 2003; Kastner et al., 1997; Sandell et al., 2007; Warkany & Schraffenberger, 1946) . When the RALDH band that appears de novo in the postnatal cortex is tested for its enzymatic characteristics by biochemical comparisons of dissected adult cortex with dorsal and ventral halves of embryonic retinas, it is indistinguishable from the embryonic RALDH3 enzyme, but its expression levels in the functional cortex are more than an order of magnitude lower (not illustrated here).
Because brief systemic applications of very high RA doses to young mouse pups result only in minor histological changes (Luo, Wagner, Crandall, et al., 2004) , the much lower RA levels synthesized by the postnatally emerging RALDH3 band would not be expected to exert a noteworthy effect on cortical anatomy. However, observations on the normal cortex seem to contradict this expectation: The stable RALDH3 band co-localizes along its entire length with striking differentials in a variety of histoarchitectonic features, all of which signify that RALDH3 delineates a neuronal circuitry with late-maturing, plastic characteristics (Wagner et al., 2006) . The brain in Figure 3 (top, left) illustrates schematically the topography of the stable RALDH3 band in the medial adult cortex. This schematic was reconstructed from serial coronal sections through a young mouse brain labeled with a RALDH3 antiserum, like the samples pointed to by the arrows for three antero-posterior cortical levels.
Two examples of differentially regulated histoarchitectonic features are illustrated in Figure 3 : parvalbumin, whose expression is down-regulated at the RALDH3 sites (top row) and the polysialated neural cell adhesion molecule (PSA-NCAM), which is up-regulated at the same cortical locations (bottom row). Parvalbumin is a calcium-binding protein marking one class of GABAergic inhibitory interneurons, whose expression in the cerebral cortex begins very late in all mammals; in the mouse cortical parvalbumin expression starts only in the 2nd postnatal week. Its potent calcium-binding capacity permits very high spiking activity, which makes this interneuron type the most critical one for functional plasticity and lateral cortical communication (Freund, 2003) . Polysialation of the neural cell adhesion molecule prevents neighboring membranes from adhering to each other and allows the mobility of neuronal profiles, as is required during embryonic development or for plastic adjustments to neuronal activity-that is, PSA-NCAM represents a marker for embryonic and modifiable neuronal circuitry (Rutishauser & Landmesser, 1996) . 
Complexity of RA Signaling in the Cortex
An inevitable follow-up question to the finding that RALDH3 co-localizes with common histological features is whether RA causes the differential expression patterns, similar to the classic discovery that a RA-soaked bead can cause a duplication of the limb bud in early chick embryos (Tickle, Alberts, Wolpert, & Lee, 1982) . For technical reasons it is not feasible to place a RA-soaked bead onto the adult cortex, but it is possible to alter the tangential position of the RALDH3 band by a genetic trick: In mice lacking neurotrophin 3 (NT-3), the RALDH3 topography is altered (Wagner et al., 2006) . In NT-3 null mutants, RALDH3 expression begins normally around birth but then fails to undergo its lateral shift and instead maintains its early postnatal topography throughout life. When the cortex of adult NT-3 null-mutant mice is analyzed histologically, the differential histoarchitectonic expression patterns are found to follow the altered RALDH3 topography (not shown here). These observations argue in favor of a causal role of RA synthesized by RALDH3, but the argument is not as convincing as the causal relationship between RA and its effect on the limb bud (Tickle et al., 1982) .
The legendary experiment by Tickle and colleagues (1982) was a breakthrough 25 years ago, and it still has an impact on the general reasoning about RA. It was done at a low stretch in developmental biology when the search for the chemical nature of the primary embryonic inducer, the organizer of Spemann, had been temporarily abandoned as hopeless, and a decade before the molecular biological revolution initiated a period of large-scale identification of genetically encoded morphogens (De Robertis, 2006; Lander, 2007) . At that time several laboratories were devising cell-biological assays for functional screens of embryonic inducers, including the polarizing region of the limb bud in early chick embryos, which has the amazing property of setting up the entire antero-posterior axis of the future chicken wing. The discovery that a RA-soaked bead could mimic the activity of the polarizing region represented the first identification of an endogenously occurring chemical as a morphogen. This landmark research preceded most understanding of the mechanisms of RA actions, including the discovery of RA receptors (Mangelsdorf et al., 1995) , and it catapulted to broad scientific fame an obscure factor that was known up to then mainly to a few experts. Although the designation of RA as a morphogen for the limb bud was transiently challenged by the discoveries of genetically encoded morphogens (Noji et al., 1991; Riddle, Johnson, Laufer, & Tabin, 1993) , it is by now clear that embryonic inducers consist of a variety of complex networks that include a multitude of diffusible peptide factors, their inhibitors and receptors, as well as RA, as critical embryonic morphogens (Lander, 2007; Plouhinec & De Robertis, 2007) .
Despite RA's well-established role as an embryonic morphogen, it is misleading to apply the embryonic reasoning to the RA function in the postnatal cerebral cortex. Embryonic morphogens exert their actions only during brief windows in very early development, but the postnatally appearing RALDH3 band marks a neuronal circuitry permanently. Most important, by the time the RALDH3 band assumes its final position, the cerebral cortex is already the product of a complex embryonic and postnatal history, which includes multiple chemical inducing events, regulatory feedback loops, and long-range interactive determination processes (Grove & Fukuchi-Shimogori, 2003) . Moreover, the presence of the RALDH3 band coexists with activity and experiencedependent influences on the fine structure of the cortex. By this time the brain represents an interwoven system, where about 20,000 genes can be expressed (Lein et al., 2007) , about 3,000 of which might be potentially influenced by RA (Cawley et al., 2004) . As questions about causes and effects become futile in view of such a complexity, we will disregard them temporarily and focus here on developing a plan of action for how to combine the RA-signaling data with current genomic information. This strategy is based on matching transcortical patterns, and its goal is to understand how the retinoid system is integrated with the known molecular mechanisms of cognitive functions and diseases.
RA Signaling Subdivides the Postnatal Cortex Into
Transcriptional Domains
Like the human genome, the entire mouse genome is sequenced by now. The small size of the mouse brain, however, provides an advantage over human data: For practically all mouse genes, the expression has been localized in the developing and/or adult brain, and the information is published on Web-based gene expression data banks. As a simple and unbiased approach, we consider the postnatally appearing cortical RALDH3 band as a singular pattern that serves as a tool to screen for genes, whose expression is upor down-regulated, irrespective of the molecular mechanisms that create the co-localizations.
For several embryonic and early postnatal ages, we searched through the Brain Gene Expression Map (BGEM) website (Magdaleno et al., 2006) for gene-expression patterns that follow the RALDH3 topography illustrated in Figure 3 . Among all the embryonic data on the BGEM site, we could not detect a corresponding pattern for any prenatal age. This makes it likely that the pattern emerges only postnatally, but lack of detection does, of course, not prove an absence in the embryo and it might only be very rare. At later postnatal stages and in the fully adult cerebral cortex, however, the RALDH3 topography marks the most common differential gene-expression pattern that is detectable all along the medial cortex. As examples, Figure 3 shows dark-field thumbnail pictures from the Allen Brain Atlas (Lein et al., 2007) , which are arranged in the same fashion as the histological parvalbumin and PSA-NCAM data. Up to now we have detected more than 400 genes whose expression is up-or down-regulated along the RALDH3 band. All of these genes are also expressed at other sites in the brain-that is, none has the same restricted expression as RALDH3.
In order to detect a functional significance in the assortment of identified genes, we did ontology searches with the Pathway Express program for the RALDH3 co-localized genes (Draghici et al., 2003) . The most common pathways are neuroactive ligandreceptor interactions and the mitogen activated kinase (MAPK) and calcium-calmodulin dependent kinase (CAMK) signaling pathways. This result is different from similar ontology searches done by Balmer and Blomhoff (2002) for all the genes they found to be regulated by RA in the most recent literature survey: They obtained a flat ontology distribution, indicative of RA roles in many different cellular functions throughout the body. These differences between the ontology-search results point to unique properties of RA signaling in the brain. The assumption that RA itself represents a significant factor is supported by the similarity in gene regulation within diffusion range of RA synthesized both by RALDH3 and RALDH2, as is obvious in the thumbnail views in Figure 3 , as well as in other pictures from the data banks: In most cases, the expression of the genes that are up-regulated along the RALDH3 band is also strong in upper cortical regions close to the RALDH2 expression in the meninges, and among the patterns of down-regulated genes, both the RALDH3 band and the uppermost cortical layers appear relatively empty.
The cAMP-Response Element Binding Transcription Factor
As explained earlier, the retinoid system itself does not posses the dynamic properties required for learning and memory. Information about dynamic events is primarily conveyed by the cAMPresponse element binding (CREB) family of transcription factors, which function as key mediators of stimulus-induced nuclear responses (Carlezon, Duman, & Nestler, 2005; Johannessen, Delghandi, & Moens, 2004; Lonze & Ginty, 2002) . In the nervous system CREB-dependent gene expression is implicated in complex and diverse processes ranging from development to plasticity and disease; it is best known for its role in learning and memory. CREB is expressed in all brain cells. It is activated by phosphorylation on Ser-133, which forms the point of convergence for a wide range of stimuli that eventually cause changes in gene expression, including growth factors, neurotransmitters, and stressors. The stimuli act on specific membrane receptors and activate a diverse range of signaling cascades. For instance, rapid physiological events that lead to transient Ca ϩϩ influx are conveyed by CAMKs, and MAPK cascades cause more sustained CREB phosphorylation (Wu, Deisseroth, & Tsien, 2001) . Phosphorylated CREB recruits the CREB-binding protein (CBP), a transcriptional co-activator, and activates gene expression with help of CBP's histone acetyl transferase (HAT) function.
The promoters of at least 4,000 genes contain functional CREBbinding sites (CREs), and strong physiological or pharmacological stimuli, such as exposure to the cAMP agonist Forskolin, cause CREB phosphorylation at most or all of these genes (Impey et al., 2004; Zhang et al., 2005) . However, in various differentiated cell lines Forskolin leads to expression of only a small subset (ϳ100) of CREB-dependent genes, and this subset differs with cell type. This indicates that CREB-dependent gene expression is context dependent, like RA-dependent processes, and that the specificity of gene expression requires additional inputs. The old molecular biological model that the specificity of gene expression is due to a combinatorial code of the several dozen transcription factors known at the time has grown over the years, as by now several thousand sequence-specific DNA-binding proteins are identified (Kadonaga, 2004) . More important, it is now becoming apparent that the signaling cascades, which carry information about dynamic stimuli, target not only CREB but also other transcriptional components, in particular the co-regulators (Rochette-Egly, 2005; Rosenfeld, Lunyak, & Glass, 2006) . The co-activators and corepressors possess themselves enzymatic activities that covalently modify the components of the basic transcriptional apparatus and the chromatin at target gene promoters, creating epigenetic changes for cellular memory and inheritance of transcriptional programs.
Particular co-activators and repressors, of which about 200 are known by now for mammalian genomes, are not transcriptionfactor specific but are shared by many (Lonard & O'Malley, 2006; Rosenfeld et al., 2006) . The CREB-binding protein CBP functions with at least 40 different transcription factors (Kalkhoven, 2004) . It is a very large protein that contains a domain for CREB interaction and a separate, nuclear-receptor interacting domain, and its HAT activity is significant for both CREB and RA regulated transcription. The classic RA pathway, which involves RAliganded nuclear receptors binding to RAREs in gene promoters, can thus directly interact with CREB-regulated gene expression at the transcriptional level via CBP. In addition, many of the identified nongenomic RA actions function through CREB-activated gene transcription (Aggarwal et al., 2006; Fernandes et al., 2007; Hughes et al., 2006; Kim et al., 2007) . Most important, rapid noncanonical RA signaling through CREB has been demonstrated for neurons isolated from the cerebral cortex of fetal rats (Canon et al., 2004) .
RA-regulated gene expression can thus converge with CREB regulation through several mechanisms, and it is likely do so preferentially in the brain for several reasons. On the one hand, the cognitive functions that are indisputably corroborated to involve retinoid actions, in particular learning, memory, and mood regulation (Chiang et al., 1998; Crandall et al., 2004; Misner et al., 2001) , are well known as CREB-regulated functions (Carlezon et al., 2005) . On the other hand, the assembly of genes that are differentially regulated at the cortical RALDH3 band has an ontology profile more similar to CREB targets than RA targets, and many are known to be regulated by CREB (Zhang et al., 2005) . Moreover, a co-operation of RA and CREB can account for the atypical characteristics of RA signaling in the brain, which cannot be explained by retinoid mechanisms alone Luo, Wagner, Grün, et al., 2004; Molotkova et al., 2007) .
RALDH3 Co-Localizes With Differential Regulation of Transcription-and Disease-Linked Genes
In addition to the convergence with CREB-regulated transcription, a high fraction of the assembly of differentially regulated genes code for factors directly or indirectly involved in many other specifics of transcription. This is reminiscent of the commentary that a significant number of neurodevelopmental disorders affecting cognition are caused by mutations in sequence-specific DNA binding proteins, transcriptional co-regulators, or factors involved in their modification (Hong, West, & Greenberg, 2005) . Examples of differentially regulated genes at RALDH3 are several transcription factors, including Thrb, the thyroid hormone receptor ␤, and Arnt2, the arylhydrocarbon-receptor nuclear translocator that represents the obligatory heterodimeric partner of the receptors for cellular responses to environmental toxins (dioxin receptor) and to hypoxia (Hif1). The gene list contains co-regulators with enzymatic activities implicated in epigenetic mechanisms, including acetylation, methylation, phosphorylation, ADP-ribosylation, ubiquitination, and ATP-dependent chromatin remodeling. Differential concentrations of components in the transcriptional apparatus are bound to influence gene expression, as this process is known to be exquisitely sensitive to protein levels and gene dosage (Rosenfeld et al., 2006) . The assembly also comprises a very large number of genes compromised in different cognitive diseases, including many genes implicated in mental retardation syndromes, Alzheimer's disease, and candidate genes for autism, schizophrenia, and other psychiatric disorders. An example is the Chd7 gene that codes for a chromodomain protein identified as the site of causative mutation in CHARGE syndrome (Vissers et al., 2004) , a form of mental retardation with one third of the cases also showing autism. The CHARGE syndrome consists of a nonrandom association of malformations, which is practically identical to retinoid embryopathy (Shenefelt, 1972; Vissers et al., 2004; Wilson et al., 1953) . The Allen data show that Chd7 is upregulated in the adult cortex along the RALDH3 band as is also the case for the Mecp2 gene mutated in Rett syndrome, another form of syndromic autism.
The caudal part of the RALDH3 band contains the dorsal visual stream (Wagner et al., 2006) -that is, the cortical circuits where motion perception and spatial vision are processed separately from form and color vision that are dealt with in the ventral stream. Psychophysical observations of children show that dorsal stream function develops later and remains plastic for a much longer time than ventral stream function and that it is selectively affected in a number of cognitive syndromes (Braddick, Atkinson, & WattamBell, 2003) . The etiology of some of these syndromes involves both genetic and environmental contributions, including schizophrenia (Keri, Kelemen, Benedek, & Janka, 2004; Schechter, Butler, Silipo, Zemon, & Javitt, 2003) and autism (Pellicano, Gibson, Maybery, Durkin, & Badcock, 2005) ; others are mainly due to mutations, including Williams syndrome, which is caused by a hemizygous microdeletion containing three genes that are critical for the cognitive symptoms (Meyer-Lindenberg et al., 2005) . The Allen data show that the expression of all three cognition-linked genes is differentially regulated along the RALDH3 band: The general transcription factor Gtf2i and the cytoplasmic linker Cyln2 are slightly higher, and the LIM-domain containing kinase Limk1 is slightly lower in this territory. Although all three genes are expressed throughout the cortex, as are most of the genes implicated in cognitive functions, the differential expression along RALDH3 ought to differentially accentuate this anatomical location with respect to functional abnormalities, which are caused by the halved gene dosage in Williams syndrome.
What Are the Unique Contributions of the RA System to the Complexity of Brain Function?
The transcortical pattern matching strategy shows that RA signaling relates tightly and selectively to a very large core of existing information on cognitive processing and diseases. As the conclusion that it will be necessary to incorporate an additional vast complexity to an already bewilderingly complicated topic is unenticing, one needs to explore in what way the retinoid system contributes an advantage. One outstanding property of RA is its diffusitivity (Lander, 2007) : As a relatively stable, stiff lipid acid RA can diffuse for longer distances through tissue than any of the known peptide signaling factors. Such a property must be especially useful in the brain, where different tasks are spatially represented in columnar or modular fashion, with specific functions occupying an assembly of interconnected neurons rather than single cells.
The most common view of RA in neuroscience is as an in vitro reagent for neural induction of stem cells and for the promotion of neuronal differentiation in neural progenitors. These are processes that occur normally during neural development, and it seems economical to use the same RA properties also for plasticity in the functional brain. In addition to RA, another transcriptional control system for neuronal determination is the neuron-response-element silencing factor (NRSF/REST; Ballas et al., 2005; Wu & Xie, 2006) . The transcriptional repressor REST, which is instrumental in a universal distinction of neuronal versus nonneuronal fate, regulates at least 900 genes. In the adult organism, REST protein levels are high in nonneuronal tissues and low in the brain. In the absence of RA or at low RA levels, REST transcription is powerfully suppressed by unliganded RA receptors bound to a RARE in its promoter. When embryonic stem cells are induced by RA to commence neuronal lineage, it binds to the repressive RAR at the REST promoter; causes release of co-repressors, recruitment of co-activators, and REST transcription; and the REST protein represses transcription of neuronal genes. A high expression of REST at early stages of neuronal fate is consistent with the reported high levels of REST mRNA in neural progenitors (Ballas et al., 2005) . Eventually, however, RA levels ought to be low to ensure low REST protein levels and stable neuronal properties in cells of the functional brain. This need for the silencing of REST must be the explanation for why overall RA synthesis in the functional brain is so surprisingly low (Kurlandsky et al., 1995) . An accommodation of both REST and RA functions could explain why RA signaling needs to be amplified in the brain and why RA-influenced modifiable neuronal circuits need to be spatially segregated from hard-wired, mature ones. The retinoid system is likely to contribute topographical information and life-cycle changes to combinatorial transcriptional mechanisms, which parcellate the postnatal cortex into relatively modifiable and comparatively more rigid domains.
